产品集中

Q2 Chemistry Journal of Biomolecular Screening Pub Date : 2008-10-01 DOI:10.1177/10870571080130091501

{"title":"产品集中","authors":"","doi":"10.1177/10870571080130091501","DOIUrl":null,"url":null,"abstract":"Cellectricon has introduced the Cellaxess®HT System, an automated system for reagent-free transfection that enables reagent-free delivery of siRNA and cDNA to host cells at a throughput of 50,000 wells per day. The system uses capillary electrode arrays for reagent-free transfection of cells directly in 384-well plates. The plates are designed for high-content screening (HCS) readout and are compatible with","PeriodicalId":15087,"journal":{"name":"Journal of Biomolecular Screening","volume":"13 1","pages":"922 - 927"},"PeriodicalIF":0.0000,"publicationDate":"2008-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/10870571080130091501","citationCount":"0","resultStr":"{\"title\":\"Product Focus\",\"authors\":\"\",\"doi\":\"10.1177/10870571080130091501\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cellectricon has introduced the Cellaxess®HT System, an automated system for reagent-free transfection that enables reagent-free delivery of siRNA and cDNA to host cells at a throughput of 50,000 wells per day. The system uses capillary electrode arrays for reagent-free transfection of cells directly in 384-well plates. The plates are designed for high-content screening (HCS) readout and are compatible with\",\"PeriodicalId\":15087,\"journal\":{\"name\":\"Journal of Biomolecular Screening\",\"volume\":\"13 1\",\"pages\":\"922 - 927\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/10870571080130091501\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biomolecular Screening\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/10870571080130091501\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Chemistry\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomolecular Screening","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10870571080130091501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Chemistry","Score":null,"Total":0}

引用次数: 0

摘要

Cellectricon推出了Cellaxess®HT系统，这是一种无试剂转染的自动化系统，每天可将siRNA和cDNA无试剂递送到宿主细胞，吞吐量为50,000孔。该系统使用毛细管电极阵列直接在384孔板上进行细胞的无试剂转染。该板设计用于高含量筛选(HCS)读出，并与

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Product Focus

Cellectricon has introduced the Cellaxess®HT System, an automated system for reagent-free transfection that enables reagent-free delivery of siRNA and cDNA to host cells at a throughput of 50,000 wells per day. The system uses capillary electrode arrays for reagent-free transfection of cells directly in 384-well plates. The plates are designed for high-content screening (HCS) readout and are compatible with

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Biomolecular Screening 生物-分析化学

CiteScore

2.41

自引率

0.00%

发文量

审稿时长

4-8 weeks

期刊介绍： Advancing the Science of Drug Discovery: SLAS Discovery reports how scientists develop and utilize novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. SLAS Discovery is a peer-reviewed journal that publishes scientific reports that enable and improve target validation, evaluate current drug discovery technologies, provide novel research tools, and incorporate research approaches that enhance depth of knowledge and drug discovery success. SLAS Discovery emphasizes scientific and technical advances in target identification/validation (including chemical probes, RNA silencing, gene editing technologies); biomarker discovery; assay development; virtual, medium- or high-throughput screening (biochemical and biological, biophysical, phenotypic, toxicological, ADME); lead generation/optimization; chemical biology; and informatics (data analysis, image analysis, statistics, bio- and chemo-informatics). Review articles on target biology, new paradigms in drug discovery and advances in drug discovery technologies. SLAS Discovery is of particular interest to those involved in analytical chemistry, applied microbiology, automation, biochemistry, bioengineering, biomedical optics, biotechnology, bioinformatics, cell biology, DNA science and technology, genetics, information technology, medicinal chemistry, molecular biology, natural products chemistry, organic chemistry, pharmacology, spectroscopy, and toxicology.